Phylogenetic relationships and ecological niche modeling of the widow spiders, genus Latrodectus Walckenaer, 1805 (Araneae: Theridiidae) in Iran

  Phylogenetic relationships and ecological niche modeling of the widow spiders, genus Latrodectus Walckenaer, 1805 (Araneae: Theridiidae) in Iran Abstract The genus Latrodectus Walckenaer, 1805, encompasses species commonly referred to as widow spiders, which display significant ecological diversity. A total of 35 morphological species within the genus Latrodectus have been identified and documented globally, with six species recognized in Iran: L. cinctus Blackwall, 1865; L. dahli Levi, 1959; L. geometricus C.L. Koch, 1841; L. pallidus O.P. Cambridge, 1872; L. revivensis Shulov, 1948; and L. tredecimguttatus (Rossi, 1790). This research employed statistical analysis to explore morphological variations and utilized molecular data to clarify the phylogenetic relationships within the genus Latrodectus in Iran. Furthermore, ecological niche models (ENMs) were constructed using maximum entropy modeling to predict the potential distribution of species identified in the country. Phyloge...

Snake Venom and Antivenom Pharmacology

 


SNAKE VENOM & ANTIVENOM Chemistry, Composition, Mechanisms and Pharmacology

Abstract

This integrated teaching session for Phase III MBBS students focused on the pharmacology and toxicology of snake venom and the principles of antivenom therapy. The lecture covered the chemistry, composition, mechanisms of action, and pharmacological effects of snake venoms and antivenoms. Rational use of antivenoms, indications, administration protocols, adverse reactions, and supportive management strategies were discussed. The session also highlighted the translational importance of venom-derived compounds in modern drug development. Recent advances in antivenom research, including recombinant human monoclonal antibodies, toxin-specific inhibitors, synthetic antibody technologies, and next-generation broad-spectrum antivenoms, were reviewed. Current discoveries and emerging approaches aimed at improving efficacy, safety, affordability, and accessibility of antivenom therapy were also explored, emphasizing their potential role in reducing the global burden of snakebite envenomation.

Ahasan, Md. (2026). Snake Venom and Antivenom Pharmacology. 10.13140/RG.2.2.27438.88646/1. ResearchGate Link to PDF Slides